Native GLP-1, for example, is quickly degraded by the enzyme dipeptidyl peptidase-4 (DPP-4) , resulting in an extremely short circulating half-life
Most side effects emerge within the first 24 to 72 hours, though the intensity and duration vary significantly from person to person based on dose escalation, individual metabolism, and genetic factors
The Operational Multiple Dosing Half-life: A Key to Defining Drug Accumulation in Patients and to Designing Extended Release Dosage Forms - NIH [2].
For instance, some researchers argue combining this peptide with semaglutide may achieve: Improved healing processes Weight management Enhanced metabolic health Other scientific reviews say BPC-157 may supplement wound therapy
BPC-157 in KLOW also accelerates new blood vessel formation
8) Abhilash, M., Varghese, M.V., Paul, M.V.S